Karyopharm Therapeutics Inc - Investor And Analyst ASH Event (Virtual) Transcript
Hello. My name is Keith, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics ASH 2020 Investor Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to Mr. Ian Karp, Karyopharm's Senior Vice President, Investor and Public Relations.
Great. Thanks so much, and thank you all for joining us on today's conference call to discuss important clinical data presented at the American Society of Hematology 2020 Annual Meeting. This is Ian Karp, and I'm joined today by Dr. Michael Kauffman, Chief Executive Officer; Dr. Jatin Shah, Chief Medical Officer; as well as my 2 guests on today's call, who will join us a bit later: Dr. James Berenson, Founder, President and Medical and Scientific Director of the Institute for Myeloma and Bone Cancer Research; and Dr. Timothy Pardee, Director
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |